Current State of Care in NMOSD With FDA-Approved Medications for Preventing Relapse: Michael Levy, MD, PhDMarch 10th 2023
The associate professor at Harvard Medical School talked about the currently approved therapies and the state of care for patients with NMOSD from a clinician perspective. [WATCH TIME: 5 minutes]
Role of HCPs in Engaging Diverse NMOSD Patient Populations in Clinical TrialsOctober 28th 2022
Mitzi Williams, MD; Mirla Avila, MD; Michael Levy, MD, PhD; and Michael Yeaman, PhD, explore how health care professionals can better engage diverse racial and ethnic groups with NMOSD to improve care and enroll in clinical trials.
SRNA Roundtable Discussion: Diagnosis, Presentation, and Treatment Decision Differences Among Rare Neuroimmune DisordersOctober 3rd 2022
Experts such as Brenda Banwell, MD; Sean Pittock, MD; and Michael Levy, MD, PhD, cover topics related to differences in rare neuroimmune disorders, how they're approached and treated.
Clinical Presentation of NMOSD and Overcoming Barriers to Access to CareSeptember 16th 2022
Mirla Avila, MD; Michael Levy, MD, PhD; and Mitzi Williams, MD, share the clinical presentation and progression of NMOSD among various racial and ethnic groups and highlight the effects of socioeconomic disparities and personal barriers on access to proper care.